OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 22.00
+1.00 (4.76%)
Aug 27, 2026, 1:26 PM JST
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 8.57 billion as of August 26, 2026. Its market cap has increased by 4.23% in one year.
Market Cap
8.57B
Enterprise Value
6.25B
Revenue
777.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.00
ChartMarket Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 8.57B, a decrease of -38.06%. That is a compound annual growth rate of -2.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 8.57B | 24.74% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 9.91B |
| SUSMED,Inc. | 9.57B |
| Nano Holdings | 9.39B |
| CellSeed | 9.15B |
| K Pharma,Inc. | 9.12B |
| Kidswell Bio | 9.05B |
| Carna Biosciences | 8.63B |
| StemCell Institute | 7.77B |